Retroperitoneal fibrosis in the military hospital of Morocco

Azizi, M.; Zajjari, Yassir; Rafik, Hicham; Kabbaj, Driss El

doi:10.4103/1319-2442.279937

Cited by 5 publications

(10 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some studies enrolled patients with non-thyroid manifestations of IgG4-RD, but further on, the authors identified that subgroups of these subjects were associated with IgG4-mediated thyroid features consistent with IgG4-RTD. We identified three such studies [ 61 , 62 , 63 ] ( Table 4 ).…”

Section: Resultsmentioning

confidence: 99%

“…We also mention one case report of Pacella et al [ 47 ] that identified a 53-year-old male with retroperitoneal fibrosis diagnosed 4 years after an episode of RT requiring decompression surgery at that moment, with both thyroid and retroperitoneal findings being elements of IgG4-RD [ 47 ]. Similarly, Azizi et al [ 63 ] reported an experience with 12 subjects diagnosed with retroperitoneal fibrosis (mean age of 57 ± 10 years); among other specific complications and co-morbidities, one patient had RT [ 63 ].…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Reshaping the Concept of Riedel’s Thyroiditis into the Larger Frame of IgG4-Related Disease (Spectrum of IgG4-Related Thyroid Disease)

Cârșote

Nistor

2023

Biomedicines

View full text Add to dashboard Cite

Recently, Riedel’s thyroiditis (RT) was assimilated into the larger spectrum of immunoglobulin IgG4-related disease (IgG4-RD) in addition to a particular frame of IgG4-related thyroid disease (IgG4-RTD), underlying IgG4-RT, IgG4-associated Hashimoto’s thyroiditis (and its fibrotic variant), and IgG4-related Graves’s disease. Our objective was to overview recent data on RT, particularly IgG4-RD and IgG4-RTD. The case and study– sample analysis (2019–2023) included 293 articles and selected 18 original studies: nine single case reports (N = 9, female/male = 2/1, aged: 34–79 years, 5/9 patients with serum IgG4 available data, 2/5 with high serum IgG4) and four case series (N = 21; 4/5 series provided data on IgG4 profile, 3/21 had serum IgG4 assays, and 2/3 had abnormally high values). IgG4-RD and thyroid findings were analyzed in three cohorts (N = 25). Another two studies (N = 11) specifically addressed IgG4-RTD components. On presentation, the patients may have hypothyroidism, transitory thyrotoxicosis, goiter, long-term history of positive anti-thyroid antibodies, and hypoechoic ultrasound thyroid pattern. The 5-year analysis (N = 66) showed the rate of serum IgG4 evaluation remained low; normal values do not exclude RT. Mandatory histological and immunohistochemistry reports point out a high content of IgG4-carrying plasma cells and IgG4/IgG ratio. Unless clinically evident, histological confirmation provides a prompt indication of starting corticoid therapy since this is the first-line option. Surgery, if feasible, is selective (non-responders to medical therapy, emergency tracheal intervention, and open/core needle biopsy). Current open issues are identifying the role of serum IgG4 assays in patients with IgG4-RD, finding out if all cases of RT are IgG4-mediated, applying IgG4-RTD criteria of differentiation among four entities, and providing an RT/IgG4-RTD guideline from diagnosis to therapy. It remains that the central aim of approaching RT in daily practice is the early index of suspicion in order to select patients referred for further procedures that provide enough histological/immunohistochemistry material to confirm RT and its high IgG4 burden.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Reshaping the Concept of Riedel’s Thyroiditis into the Larger Frame of IgG4-Related Disease (Spectrum of IgG4-Related Thyroid Disease)

Cârșote

Nistor

2023

Biomedicines

View full text Add to dashboard Cite

show abstract

“…Although the specific pathogenesis is not well understood but it has been proposed that there is an exaggerated immune response triggered by atherosclerotic plaques in the aorta. Recently, a few case reports on the association between IAAA and RPF were published [ 11–13 ]. In the recent study from 2022, Yardimci et al.…”

Section: Discussionmentioning

confidence: 99%

“…Azizi et al. [ 11 ] found one case of IAAA among 12 cases of RPF. They stressed on the basis of this one case that regression of the fibrous plaque remains controversial in RPF secondary to the aortic aneurysm, even after surgical treatment of the latter.…”

Section: Discussionmentioning

confidence: 99%

“…Despite, the fact that the first description of RPF is more than 100 year old and came from the case report of Albarran in 1905 [ 30 ], there is still no answer in the published literature on the pathogenesis of this rare entity. Mainly urorenal presentation is reported, although some associations between IAAA and RPF were reported [ 11–13 ] in small series. Therefore, taking into account our long-term clinical experience we presented two subpopulations with RPF in the recent review [ 2 ].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Retroperitoneal fibrosis, a rare entity with urorenal and vascular subtypes – preliminary data

et al. 2022

View full text Add to dashboard Cite

Introduction Retroperitoneal fibrosis (RPF) is a rare disease associated with the formation of hard inflammatory and fibrous tissue in the retroperitoneum. Taking into consideration the fact that RPF is a rare disease with different subtypes, we compared the basal clinical and biochemical characteristics of the vascular and urorenal subtypes. Patients and methods From January 2005 until December 2021, 27 patients were identified as vascular subtype (18 males) and 11 as urorenal subtype (9 males). Results Patients with a primary urorenal origin had significantly worse kidney function as reflected by serum creatinine and eGFR (both p < 0.001); they also had higher serum cholesterol ( p < 0.01). Hypertension, diabetes, hyperlipidemia and nicotinism were significantly more prevalent in vascular subtype (all p < 0.001). Conclusion Vascular subtype is more prevalent in our study with more cardiovascular risk factor present. Due to the diversity of symptoms, diagnosis of RPF becomes a challenge for specialists as well as therapy.

show abstract

Ergotamine

2021

Reactions Weekly

View full text Add to dashboard Cite

Retroperitoneal fibrosis in the military hospital of Morocco

Cited by 5 publications

References 12 publications

Reshaping the Concept of Riedel’s Thyroiditis into the Larger Frame of IgG4-Related Disease (Spectrum of IgG4-Related Thyroid Disease)

Reshaping the Concept of Riedel’s Thyroiditis into the Larger Frame of IgG4-Related Disease (Spectrum of IgG4-Related Thyroid Disease)

Retroperitoneal fibrosis, a rare entity with urorenal and vascular subtypes – preliminary data

Ergotamine

Contact Info

Product

Resources

About